CECR1 抗体 (N-Term)
Quick Overview for CECR1 抗体 (N-Term) (ABIN2782907)
抗原
See all CECR1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- N-Term
-
序列
- MQFRFAHPTP RPSEKCSKWI LLEDYRKRVQ NVTEFDDSLL RNFTLVTQHP
-
预测反应
- Human: 100%
-
产品特性
- This is a rabbit polyclonal antibody against CECR1. It was validated on Western Blot using a cell lysate as a positive control.
-
纯化方法
- Affinity Purified
-
免疫原
- The immunogen is a synthetic peptide directed towards the N terminal region of human CECR1
-
-
-
-
应用备注
- Optimal working dilutions should be determined experimentally by the investigator.
-
说明
-
Antigen size: 511 AA
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- Lot specific
-
缓冲液
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freeze-thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- CECR1 (Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1))
-
别名
- CECR1
-
背景
-
CECR1 a member of a subfamily of the adenosine deaminase protein family. It may act as a growth factor and have adenosine deaminase activity. This gene may be responsible for some of the phenotypic features associated with cat eye syndrome. Two transcript variants encoding distinct isoforms have been identified for this gene.This gene encodes a member of a subfamily of the adenosine deaminase protein family. The encoded protein may act as a growth factor and have adenosine deaminase activity. It may be responsible for some of the phenotypic features associated with cat eye syndrome. Two transcript variants encoding distinct isoforms have been identified for this gene.
Alias Symbols: IDGFL, ADA2, ADGF
Protein Interaction Partner: SRRM2,
Protein Size: 511 -
分子量
- 56 kDa
-
基因ID
- 51816
-
NCBI登录号
- NM_017424, NP_059120
-
UniProt
- Q9NZK5
-
途径
- Ribonucleoside Biosynthetic Process
抗原
-